EDITORIAL
Published on 11 Aug 2022
Editorial: Glucocorticoid and bone: Friend or foe
doi 10.3389/fendo.2022.995124
- 1,048 views
- 2 citations
- Frontiers in Endocrinology
- Bone Research
- Research Topics
- Glucocorticoid and bone: friend or foe?
Glucocorticoid and bone: friend or foe?
16k
Total downloads
53k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 14 Jul 2022
Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves’ Orbitopathy: A Pilot Study
doi 10.3389/fendo.2022.893600
- 1,164 views
- 4 citations
REVIEW
Published on 31 Mar 2022
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
doi 10.3389/fendo.2022.835720
- 6,524 views
- 34 citations
ORIGINAL RESEARCH
Published on 23 Mar 2022
Bone Mineral Density Assessment by Quantitative Computed Tomography in Glucocorticoid-Treated Boys With Duchenne Muscular Dystrophy: A Linear Mixed-Effects Modeling Approach
doi 10.3389/fendo.2022.860413
- 1,827 views
- 5 citations
MINI REVIEW
Published on 16 Feb 2022
The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides
doi 10.3389/fendo.2022.806361
- 3,053 views
- 7 citations
MINI REVIEW
Published on 10 Jan 2022
Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases
doi 10.3389/fendo.2021.815386
- 3,686 views
- 15 citations
REVIEW
Published on 15 Dec 2021
When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
doi 10.3389/fendo.2021.782118
- 11,142 views
- 18 citations
MINI REVIEW
Published on 12 Nov 2021
The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
doi 10.3389/fendo.2021.744647
- 7,662 views
- 11 citations
ORIGINAL RESEARCH
Published on 30 Sep 2021
Cortisol and Phosphate Homeostasis: Cushing’s Syndrome Is Associated With Reversible Hypophosphatemia
doi 10.3389/fendo.2021.733793
- 7,518 views
- 8 citations
ORIGINAL RESEARCH
Published on 27 Sep 2021
Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
doi 10.3389/fendo.2021.753185
- 5,999 views
- 8 citations
REVIEW
Published on 27 Aug 2021
Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe
doi 10.3389/fendo.2021.733611
- 3,835 views
- 12 citations
Published in
Frontiers in Endocrinology
- Bone Research
Impact
- 53kTopic views
- 36kArticle views
- 16kArticle downloads